PRLog (Press Release) –
San Francisco, CA and London, UK; 27 February 2007. With headquarters in Basel, Switzerland, Novartis is recognised as being one of the strongest performing pharmaceutical companies in terms of sales, high revenue growth, acquisitions, breadth of portfolio, product launches and pipeline developments. By 2010, the Novartis group will generate $57bn, with double-digit growth. These are some of the findings from the “Novartis 2007-2012” report, published by the business information company visiongain.
Novartis appears to have a golden touch that even other leading pharmaceutical companies envy. Report author Dr Gordon Low said: " With its above-average growth, visiongain predicts that Novartis will rise even higher in the ranks of pharmaceutical giants within the foreseeable future. In particular, there will be significant developments in R&D and international operations.”
Competitors, partners and companies seeking strategic alignments with a leading pharmaceutical company therefore cannot afford to ignore developments in Novartis.
The purpose of this visiongain report is to examine the commercial prospects for Novartis in the global healthcare market. Novartis is already competing very at the forefront of the industry, generating $37bn net sales in 2006. Novartis 2007-2012, critically examines the Novartis group through comprehensive research, market forecasting and qualitative analyses. The main emphasis is on prescription drugs, but other aspects including Sandoz, OTC and vaccines are discussed.
ENDS
Notes for editors:
To receive your complimentary overview of this report please send an email to Sara Peerun sara.peerun@visiongain.com, telephone Sara on +44 (0) 20 7549 1987 or visit the media section on www.visiongainintelligence.com. Please include your full name, title of publication, contact telephone number, email and details of where you saw this release. Upon receipt of this information, an overview will be emailed to you.
Background:
Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and E-Zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the Defence sector.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. Based in London, UK, visiongain produce a host of business-2-business conferences, newsletters, management reports and E-Zines focusing on the Financial markets, the Pharmaceutical, Telecoms industries and the Defence sector.
